The cryptocurrency craze has infected the real world economy, driving up the prices of GPUs (graphics chips used for playing 3-D computer games that are also really good at crypto calculations). Mining Ethereum with GPUs has become an increasingly profitable endeavour largely because the price of Ethereum went up about 170 times from $8.24 at the beginning of 2017 to a peak of around $1400. Mid and high-end GPUs are selling out everywhere, retailing for 2 to 3 times their suggested retail price. PC Part Picker has some good data on market pricing of GPUs such as the Radeon RX 570.
Note that computer hardware normally depreciates over time, roughly halving in price every 1.5 to 2 years due to Moore’s Law. Instead of depreciating, most GPUs have appreciated wildly thanks to rising Ethereum prices.
If the crypto mining market collapses (due to a broad collapse in cryptocurrency prices), I am willing to speculate that AMD’s valuation would better reflects its difficulties in generating profits. Historically AMD has never been a particularly profitable company, losing $7.82B of the $8.34B in capital raised. In YE2017 AMD earned $62M before taxes, buoyed by aggressive accounting (perhaps $40M-97M+?) and unusually high GPU demand (perhaps a few hundred million?). If AMD returns to its money-losing ways, its shares ought to trade closer to its $0.611B book value (plus the value of its x86 license) rather than its current $10.83B market cap.
US health insurance stocks have performed extremely well. Even if you had bought the worst ones, performance would have been similar to the S&P 500. Why?
While the overall US healthcare system is dysfunctional relative to those in other developed countries, a broken healthcare system doesn’t explain why insurance stocks have done better than hospital stocks. While hospitals engage in abusive practices such as surprise out-of-network medical bills (balance billing), hospital stocks have been mediocre investments. A better supported explanation is scale. One manifestation of scale is in dialysis treatment, a unique market where Medicare is the biggest negotiator with at least 90% of patients. Commercial payers, with their lack of scale in this situation, are charged many times what Medicare pays. SIRF’s analysis puts it at roughly $1,050 per treatment versus $250. Of course, no health insurer enjoys 90%+ market share so their scale advantages are smaller.
Here’s a look at how market cap (a proxy for size) correlates with return on assets:
The price of Bitcoin has fallen significantly from its peak… perhaps foreshadowing a quick collapse. Perhaps short positions in Bitcoin will work out quickly. But who knows… short positions may turn out to be extremely dangerous as Bitcoin may skyrocket even more. Here are some quick notes…
For the image above, the columns are:
- Green = shortable, dark green = no borrow, red = Interactive Brokers won’t let you short it.
- Borrow rate (retail rates).